EP1435926A4 - Verfahren zur behandlung und prävention von störungen des zentralen nervensystems im zusammenhang mit einer veränderung der glutamatergen neurotransmission durch verabreichung von 2-aminobenzolsulfonamid-derivaten - Google Patents

Verfahren zur behandlung und prävention von störungen des zentralen nervensystems im zusammenhang mit einer veränderung der glutamatergen neurotransmission durch verabreichung von 2-aminobenzolsulfonamid-derivaten

Info

Publication number
EP1435926A4
EP1435926A4 EP02769353A EP02769353A EP1435926A4 EP 1435926 A4 EP1435926 A4 EP 1435926A4 EP 02769353 A EP02769353 A EP 02769353A EP 02769353 A EP02769353 A EP 02769353A EP 1435926 A4 EP1435926 A4 EP 1435926A4
Authority
EP
European Patent Office
Prior art keywords
disturbances
alteration
administration
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02769353A
Other languages
English (en)
French (fr)
Other versions
EP1435926A2 (de
Inventor
Giuseppe Cannazza
Carlo Parenti
Wolfgang Lindner
Giulia Puia
Mario Baraldi
Daniela Braghiroli
Annalisa Tait
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rett Corp
Original Assignee
Rett Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rett Corp filed Critical Rett Corp
Publication of EP1435926A2 publication Critical patent/EP1435926A2/de
Publication of EP1435926A4 publication Critical patent/EP1435926A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
EP02769353A 2001-05-08 2002-05-07 Verfahren zur behandlung und prävention von störungen des zentralen nervensystems im zusammenhang mit einer veränderung der glutamatergen neurotransmission durch verabreichung von 2-aminobenzolsulfonamid-derivaten Withdrawn EP1435926A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITBO20010271 2001-05-08
IT2001BO000271A ITBO20010271A1 (it) 2001-05-08 2001-05-08 Metodo per il trattamento e la prevenzione dei disturbi del sistema nervoso centrale associati ad una alterazione della neurotrasmissione gl
PCT/US2002/014262 WO2002089734A2 (en) 2001-05-08 2002-05-07 Method for treatment and prevention of disturbances of the central nervous system associated with an alteration of glutamatergic neurotransmission by administration of 2-aminobenzenesulfonamide derivatives

Publications (2)

Publication Number Publication Date
EP1435926A2 EP1435926A2 (de) 2004-07-14
EP1435926A4 true EP1435926A4 (de) 2005-11-23

Family

ID=11439316

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02769353A Withdrawn EP1435926A4 (de) 2001-05-08 2002-05-07 Verfahren zur behandlung und prävention von störungen des zentralen nervensystems im zusammenhang mit einer veränderung der glutamatergen neurotransmission durch verabreichung von 2-aminobenzolsulfonamid-derivaten

Country Status (4)

Country Link
EP (1) EP1435926A4 (de)
AU (1) AU2002308614A1 (de)
IT (1) ITBO20010271A1 (de)
WO (1) WO2002089734A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070182A1 (es) 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
WO2007076875A2 (en) * 2006-01-06 2007-07-12 Aarhus Universitet Compounds acting on the serotonin transporter
EP3311842A1 (de) 2013-06-13 2018-04-25 VeroScience LLC Zusammensetzungen und verfahren zur behandlung von stoffwechselstörungen

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0815861A1 (de) * 1996-06-28 1998-01-07 F. Hoffmann-La Roche Ag Sulfonamide und ihre Verwendung
WO2000012073A1 (en) * 1998-08-28 2000-03-09 Smithkline Beecham P.L.C. Use of 5ht-6 antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722502B1 (fr) * 1994-07-12 1996-08-23 Adir Nouveau derive de benzothiadiazine, son procede depreparation et les compositions pharmaceutiques qui le contiennent
US6083947A (en) * 1996-01-29 2000-07-04 The Regents Of The University Of California Method for treating sexual dysfunctions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0815861A1 (de) * 1996-06-28 1998-01-07 F. Hoffmann-La Roche Ag Sulfonamide und ihre Verwendung
WO2000012073A1 (en) * 1998-08-28 2000-03-09 Smithkline Beecham P.L.C. Use of 5ht-6 antagonists

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
D.J.HEALY ET ALL.: "Iontropic glutamate receptor modulation of 5-HT6 and 5-HT7 mRNA expression in rat brain", NEUROPSYCHOPHARMACOLOGY, vol. 21, no. 3, 1999, pages 341 - 351, XP002347588 *

Also Published As

Publication number Publication date
AU2002308614A1 (en) 2002-11-18
ITBO20010271A0 (it) 2001-05-08
WO2002089734A2 (en) 2002-11-14
ITBO20010271A1 (it) 2002-11-08
WO2002089734A3 (en) 2003-03-06
EP1435926A2 (de) 2004-07-14

Similar Documents

Publication Publication Date Title
EP1471909A4 (de) Pharmazeutische zusammensetzung und verfahren zur behandlung von erkrankungen des zentralen nervensystems
WO2003049675A3 (en) Treating muscle wasting with selective androgen receptor modulators
EP1436029A4 (de) Verfahren und gerät zur gewährleistung der qualität und sicherheit der arzneimittelverabreichung und medizinische produkte und sets
HK1070358A1 (en) Process for the preparation of 7-substituted-3-qu inoline and 3-quinol-4-one carbonitriles.
IL163102A (en) Dihydrobenzodiazepin-2-one derivatives, process for their preparation and use thereof in the preparation of medicaments for the treatment of neurological disorders
AU2002211612A1 (en) Methods for the treatment of a traumatic central nervous system injury
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
IL158289A (en) Mercaptoacetylamide derivatives, a process for their preparation and their use as medicaments for the treatment of hypertension and chf
HUP0301333A3 (en) Pharmaceutical superdisintegrant, process for its preparation and its use
AU6910600A (en) Methods for the treatment of mental disorders
AU5636300A (en) Use of creatine or creatine analogs for the prevention and treatment of transmissible spongiform encephalopathies
WO2005091987A3 (en) Method of treating down syndrome
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
HRP20031067A2 (en) Pharmaceutical formulation having masked taste and method for the production thereof
WO2000064423A3 (fr) Utilisation du saredutant et de ses sels pharmaceutiquement acceptables dans le traitement ou la prevention des troubles de l'humeur d'adaptation et de l'anxiete-depression
AU2003251904A1 (en) Combinations of drugs for the treatment of neoplasms
AU2002247973A1 (en) Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases
EP1435926A4 (de) Verfahren zur behandlung und prävention von störungen des zentralen nervensystems im zusammenhang mit einer veränderung der glutamatergen neurotransmission durch verabreichung von 2-aminobenzolsulfonamid-derivaten
WO2004034889A3 (en) Photodynamic therapy for ocular neovascularization
EP1455780A4 (de) Neue benzodifuranimidazolin- und benzofuranimidazolin-derivate und ihre verwendung zur behandlung von glaukom
AU2003202255A1 (en) Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
HK1070900A1 (en) Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds
GB0205894D0 (en) Method and apparatus for the administration of benefits
AU2003291882A1 (en) Pharmaceutical combinations and methods for the treatment of leukemia
AUPR665401A0 (en) A drug and method for the treatment of osteonecrosis

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040319

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20051012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051201